The targeting of the sole cyclin D1 is not adequate for mantle cell lymphoma and myeloma therapies.
Tchakarska
Guergana
G
Le Lan-Leguen
Anne
A
Roth
Lucile
L
Sola
Brigitte
B
D045744:Cell Line, Tumor; D049109:Cell Proliferation; D019938:Cyclin D1 / Q000235:genetics*; D056742:Cyclin D2 / Q000235:genetics; D016193:G1 Phase; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000235:genetics / Q000473:pathology / Q000628:therapy; D009101:Multiple Myeloma / Q000235:genetics / Q000473:pathology / Q000628:therapy; D034622:RNA Interference; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016196:S Phase
D056742:Cyclin D2; D019938:Cyclin D1
Leukemia. 2009 Jan;23(1):10-24
18843284
Mol Cell Biol. 2005 Feb;25(3):1081-8
15657434
Leuk Lymphoma. 2006 Feb;47(2):195-205
16321849
J Immunol. 2004 Sep 1;173(5):2901-7
15322145
J Clin Invest. 2008 May;118(5):1750-64
18431519
Leukemia. 2008 Nov;22(11):2097-105
18685613